Save
Email
Print
Share
RSSBrowse News Stories
61 to 70 of 75 stories
view headlines only
-
Drug May Hinder Recovery From Heart Attacks
November 17, 2004 — Some new generation COX-2 inhibitors may not allow heart attack patients to recover fully, research indicates. Researchers at the University of Alberta have discovered a basic cellular process the ... > full story -
Mayo Researchers Define Celecoxib Pathways And Mechanisms For Tumor Reduction
November 8, 2004 — The anti-inflammatory drug Celebrex, or celecoxib, reduces tumor mass by encouraging cell death and discouraging both cell proliferation and the sprouting of new blood vessels that feed growing ... > full story -
FDA Issues Public Health Advisory On Vioxx As Its Manufacturer Voluntarily Withdraws The Product
October 6, 2004 — The Food and Drug Administration (FDA) today acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by ... > full story -
Vanderbilt Research Shows High Doses Of Popular Pain Reliever Prescribed Despite Heart Risk
July 13, 2004 — The evidence is growing: chronic, high-dose consumption of the arthritis pain reliever Vioxx can raise blood pressure and the risk of serious heart problems. Yet a "substantial number" of ... > full story -
New Non-Aspirin Pain Drug Proves Effective Against Recurrent Prostate Cancer
June 10, 2004 — Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely ... > full story -
For Those Who Take Painkillers Regularly, A Heartburn Pill A Day May Keep Ulcers Away
October 15, 2003 — For those who take certain painkiller drugs regularly to help ease arthritis pain or other chronic aches, the relief comes with a tradeoff: a quadrupled chance of developing painful ulcers over the ... > full story -
Northwestern Memorial Hospital Studying Arthritis Drug's Potential In Fighting Cancer
July 1, 2003 — A research study under way at Northwestern Memorial Hospital is trying to find out if the popular anti-inflammatory drug Celebrex might do more than ease arthritis pain. Researchers at Northwestern ... > full story -
Colonoscopy Far More Cost-Effective Against Colon Cancer Than Promising Cox II Drugs, Study Predicts
May 7, 2003 — A new study gives Americans over 50 one more reason not to put off having a colonoscopy to check for colon cancer and its forerunners. Not only is the screening technique already known to be very ... > full story -
COX-2 Enzyme Instrumental In Parkinson's Disease
April 8, 2003 — Research by neurologists at Columbia University suggests that COX-2 inhibitors like Celebrex and Vioxx may someday help Parkinson's disease patients by preventing the death of neurons that ... > full story -
Researchers Show COX-2 Inhibitors Interfere With Bone Growth, Healing
November 20, 2002 — Researchers at Stanford University Medical Center have found that selective COX-2 inhibitors - a class of medications widely prescribed for painful inflammatory conditions such as osteoarthritis and ... > full story
Search ScienceDaily
Number of stories in archives: 137,302
more 
